IPO market shows signs of life
After a string of disappointing debuts, the IPO market showed signs of life on Thursday, with shares of four newly public companies each shooting up more than 20 percent in their first day of trading.
Louisville, Colorado-based GlobeImmune, the developer of biopharmaceuticals aimed at treating cancer and infectious diseases, filed for an IPO Tuesday, saying it is looking to raise up to $69M on the NASDAQ Global Market.